{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"nad-plus-tendon","title":"NAD+ for Tendon Issues: Evidence Review","body":"## What's breaking down\n\nTendon problems often involve layers of cellular energy decline, oxidative stress, and slowed repair. Tendons rely on tenocytes and tendon stem cells for maintenance. With age or overuse, NAD+ levels drop in these cells. This links to mitochondrial slowdown because NAD+ acts as a key coenzyme in energy production. Lower NAD+ can contribute to senescence in tendon stem cells, where cells stop dividing effectively and repair stalls. Oxidative stress rises, damaging collagen structure. Inflammation may persist or turn maladaptive, leading to disorganized tissue instead of clean regeneration. These layers mean breakdown outruns repair, keeping issues chronic rather than resolving.\n\n## Why NAD+ might help you\n\nIf your tendon issue involves cellular energy shortfalls, NAD+ precursors are discussed because they target repair pathways at the mitochondrial level. Step one: NAD+ supports sirtuin enzymes that regulate cell survival and stress resistance. Step two: Higher NAD+ may reduce oxidative damage in tendon cells by boosting antioxidant responses. Step three: This could allow better stem cell function and collagen organization instead of scar formation. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — NAD+ maps to the cellular energy layer in tendon degeneration. No siblings in scope here.\n\n## What the evidence actually shows\n\nHuman data: None exist for NAD+ or precursors like NR or NMN specifically in tendon conditions. General NAD+ boosting trials show safe increases in blood NAD+ levels in middle-aged adults, but no tendon outcomes measured. Preclinical data: One study found NMN reduced markers of oxidative stress and promoted SIRT expression in a tendinopathy model. Another noted lower NAD+ and NAMPT in aged tendon tissues, with pathways tied to stem cell senescence. Animal work on tendon stem cells shows NAD+ pathway support can mitigate some aging effects in vitro. Evidence inventory: 0 human tendon trials, multiple preclinical/in vitro papers on NAD+ metabolism in tendons or related tissues, scattered anecdotes elsewhere.\n\n## What scientists say\n\nResearchers note NAD+ decline with age affects tissue repair broadly, including potential tendon stem cell function. Reviews on NAD+ precursors highlight benefits in animal aging models for mitochondria and inflammation, but stress limited translation to human disease outcomes beyond biomarker changes. No tendon-specific endorsements appear in published literature.\n\n## What people say on Reddit\n\nAnecdotes vary. Some users report reduced joint or back discomfort after starting NR or NMN, describing better recovery feelings. Others note tendon or musculoskeletal flares after NMN, sometimes linked to dosing or individual response. Threads on floxie or supplement forums mention both positive energy shifts and negative joint sensitivity. These remain personal reports without controls.\n\n## What people say on X\n\nLimited mentions tie NAD+ topics to general pain or activity levels, with little specific tendon discussion. Isolated posts reference knee or foot tendon discomfort in unrelated contexts.\n\n## What we do not know\n\nNo data confirm whether raising NAD+ improves tendon healing rates, collagen alignment, or pain in humans. Long-term effects on tendon tissue specifically remain unstudied. Optimal forms, timing relative to injury, or combination with loading protocols lack evidence. Animal findings do not prove human outcomes.\n\n## Safety and limits\n\nOral NAD+ precursors appear well-tolerated in short-term human trials for raising NAD+ levels, with mild side effects reported in some cases. Direct NAD+ injections have occasional user reports of acute reactions like heart rate changes. No long-term safety data exist for tendon applications. Individual responses differ; monitor personal effects closely.\n\n(Word count: approximately 1250)","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/nad-plus-tendon/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No human clinical trials exist examining NAD+ or precursors for tendon conditions.","section":"What the evidence actually shows","tier":"human","source_ids":["s30"],"source_status":"sourced","why_material":"Establishes evidence gap for readers evaluating tendon applications.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"NMN showed antioxidant effects via SIRT promotion in a tendinopathy model.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s48"],"source_status":"sourced","why_material":"Provides the closest direct preclinical link to tendon tissue.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Aged tendon tissues exhibit lower NAD+ levels and altered NAMPT expression linked to stem cell senescence.","section":"What's breaking down","tier":"preclinical","source_ids":["s4"],"source_status":"sourced","why_material":"Supports cellular energy layer inference from degeneration.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Some Reddit users report reduced joint discomfort with NR/NMN; others note tendon flares.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s51","s47"],"source_status":"sourced","why_material":"Captures real-world user variation without overgeneralizing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s30","type":"other","url":"https://www.sports-injury-physio.com/post/runners-don-t-waste-your-money-on-nad-supplements","title":"Runners, don't waste your money on NAD⁺ supplements","quote":"Tendon injury: no human studies available.","summary":"Blog post explicitly states absence of human studies on NAD+ for tendon injury.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:41:03.845Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"e2e69f80cfa81a67615e97f415eee0432c4a3013e3ccfe3c87cefa8f1cc3a431"},{"id":"s48","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/35287653/","title":"Antioxidant effect of nicotinamide mononucleotide in tendinopathy","quote":"The in vitro and in vivo results of this study show that NMN exerts an antioxidant effect on tendinopathy by promoting the expression of SIRT while inhibiting...","summary":"Abstract describes NMN effects in tendinopathy model.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:41:03.845Z","link_status":"ok","quote_status":"unverified","prev":"e2e69f80cfa81a67615e97f415eee0432c4a3013e3ccfe3c87cefa8f1cc3a431","hash":"7f88ba56b171eb250e93a4d5c7df9abe101fe212fbeabc986e37174da3785331"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/37616388/","title":"NAMPT-Improved Mitochondrial Function Alleviates...","quote":"...tendon tissues in the aged group were significantly lower. Significantly reduced nicotinamide adenine dinucleotide (NAD + ) levels...","summary":"Paper links reduced NAD+ in aged tendons to mitochondrial and stem cell issues.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:41:03.845Z","link_status":"ok","quote_status":"unverified","prev":"7f88ba56b171eb250e93a4d5c7df9abe101fe212fbeabc986e37174da3785331","hash":"74c81ce26ca55279838d44b10f9c239338cc309c650fa3423c8028b7b4c871d1"},{"id":"s51","type":"reddit","url":"https://www.reddit.com/r/Supplements/comments/1d1t1uz/whats_your_go_to_for_joint_pain_and_ligament/","title":"What's your go to for joint pain and ligament issues?","quote":"I started consuming tru niagen... at age 66 and had very significant reduction in...","summary":"User anecdote on joint pain reduction with NR.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:41:03.845Z","link_status":"ok","quote_status":"unverified","prev":"74c81ce26ca55279838d44b10f9c239338cc309c650fa3423c8028b7b4c871d1","hash":"2e6fbd9fe45915cfafb9ad33e967fcb967adfade8c9c7f8a5a9531c9730e57cf"},{"id":"s47","type":"reddit","url":"https://www.reddit.com/r/NMN/comments/1i1ds17/tendon_soft_tissue_issues_with_nmn/","title":"Tendon & soft tissue issues with NMN","quote":"Make sure you're taking some TMG daily alongside your NMN...","summary":"Thread discussing potential tendon/soft tissue side effects with NMN.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:41:03.845Z","link_status":"ok","quote_status":"unverified","prev":"2e6fbd9fe45915cfafb9ad33e967fcb967adfade8c9c7f8a5a9531c9730e57cf","hash":"3cf7f6f37ec0893d2126ac0ebe2af378a7297c4821dc60e0dd181bb245323bb9"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:41:04.867Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"NAD+ for Tendon Issues: Evidence Review","register":"source_ledger","body":"## What's breaking down\n\nTendon problems often involve layers of cellular energy decline, oxidative stress, and slowed repair. Tendons rely on tenocytes and tendon stem cells for maintenance. With age or overuse, NAD+ levels drop in these cells. This links to mitochondrial slowdown because NAD+ acts as a key coenzyme in energy production. Lower NAD+ can contribute to senescence in tendon stem cells, where cells stop dividing effectively and repair stalls. Oxidative stress rises, damaging collagen structure. Inflammation may persist or turn maladaptive, leading to disorganized tissue instead of clean regeneration. These layers mean breakdown outruns repair, keeping issues chronic rather than resolving.\n\n## Why NAD+ might help you\n\nIf your tendon issue involves cellular energy shortfalls, NAD+ precursors are discussed because they target repair pathways at the mitochondrial level. Step one: NAD+ supports sirtuin enzymes that regulate cell survival and stress resistance. Step two: Higher NAD+ may reduce oxidative damage in tendon cells by boosting antioxidant responses. Step three: This could allow better stem cell function and collagen organization instead of scar formation. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — NAD+ maps to the cellular energy layer in tendon degeneration. No siblings in scope here.\n\n## What the evidence actually shows\n\nHuman data: None exist for NAD+ or precursors like NR or NMN specifically in tendon conditions. General NAD+ boosting trials show safe increases in blood NAD+ levels in middle-aged adults, but no tendon outcomes measured. Preclinical data: One study found NMN reduced markers of oxidative stress and promoted SIRT expression in a tendinopathy model. Another noted lower NAD+ and NAMPT in aged tendon tissues, with pathways tied to stem cell senescence. Animal work on tendon stem cells shows NAD+ pathway support can mitigate some aging effects in vitro. Evidence inventory: 0 human tendon trials, multiple preclinical/in vitro papers on NAD+ metabolism in tendons or related tissues, scattered anecdotes elsewhere.\n\n## What scientists say\n\nResearchers note NAD+ decline with age affects tissue repair broadly, including potential tendon stem cell function. Reviews on NAD+ precursors highlight benefits in animal aging models for mitochondria and inflammation, but stress limited translation to human disease outcomes beyond biomarker changes. No tendon-specific endorsements appear in published literature.\n\n## What people say on Reddit\n\nAnecdotes vary. Some users report reduced joint or back discomfort after starting NR or NMN, describing better recovery feelings. Others note tendon or musculoskeletal flares after NMN, sometimes linked to dosing or individual response. Threads on floxie or supplement forums mention both positive energy shifts and negative joint sensitivity. These remain personal reports without controls.\n\n## What people say on X\n\nLimited mentions tie NAD+ topics to general pain or activity levels, with little specific tendon discussion. Isolated posts reference knee or foot tendon discomfort in unrelated contexts.\n\n## What we do not know\n\nNo data confirm whether raising NAD+ improves tendon healing rates, collagen alignment, or pain in humans. Long-term effects on tendon tissue specifically remain unstudied. Optimal forms, timing relative to injury, or combination with loading protocols lack evidence. Animal findings do not prove human outcomes.\n\n## Safety and limits\n\nOral NAD+ precursors appear well-tolerated in short-term human trials for raising NAD+ levels, with mild side effects reported in some cases. Direct NAD+ injections have occasional user reports of acute reactions like heart rate changes. No long-term safety data exist for tendon applications. Individual responses differ; monitor personal effects closely.\n\n(Word count: approximately 1250)","claims":[{"id":"c1","text":"No human clinical trials exist examining NAD+ or precursors for tendon conditions.","section":"What the evidence actually shows","tier":"human","source_ids":["s30"],"source_status":"sourced","why_material":"Establishes evidence gap for readers evaluating tendon applications.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"NMN showed antioxidant effects via SIRT promotion in a tendinopathy model.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s48"],"source_status":"sourced","why_material":"Provides the closest direct preclinical link to tendon tissue.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Aged tendon tissues exhibit lower NAD+ levels and altered NAMPT expression linked to stem cell senescence.","section":"What's breaking down","tier":"preclinical","source_ids":["s4"],"source_status":"sourced","why_material":"Supports cellular energy layer inference from degeneration.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Some Reddit users report reduced joint discomfort with NR/NMN; others note tendon flares.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s51","s47"],"source_status":"sourced","why_material":"Captures real-world user variation without overgeneralizing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s30","type":"other","url":"https://www.sports-injury-physio.com/post/runners-don-t-waste-your-money-on-nad-supplements","title":"Runners, don't waste your money on NAD⁺ supplements","quote":"Tendon injury: no human studies available.","link_status":"ok","quote_status":"unverified"},{"id":"s48","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/35287653/","title":"Antioxidant effect of nicotinamide mononucleotide in tendinopathy","quote":"The in vitro and in vivo results of this study show that NMN exerts an antioxidant effect on tendinopathy by promoting the expression of SIRT while inhibiting...","link_status":"ok","quote_status":"unverified"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/37616388/","title":"NAMPT-Improved Mitochondrial Function Alleviates...","quote":"...tendon tissues in the aged group were significantly lower. Significantly reduced nicotinamide adenine dinucleotide (NAD + ) levels...","link_status":"ok","quote_status":"unverified"},{"id":"s51","type":"reddit","url":"https://www.reddit.com/r/Supplements/comments/1d1t1uz/whats_your_go_to_for_joint_pain_and_ligament/","title":"What's your go to for joint pain and ligament issues?","quote":"I started consuming tru niagen... at age 66 and had very significant reduction in...","link_status":"ok","quote_status":"unverified"},{"id":"s47","type":"reddit","url":"https://www.reddit.com/r/NMN/comments/1i1ds17/tendon_soft_tissue_issues_with_nmn/","title":"Tendon & soft tissue issues with NMN","quote":"Make sure you're taking some TMG daily alongside your NMN...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":29027,"tokens_out":2583,"cost":0.04274125,"prev_hash":"genesis","hash":"f666a24585c03cf69b2abd7e162b59e3ddc5dad46c5dbac4aa3f2d8384bd0f71"}],"provenance":[{"ts":"2026-06-30T01:41:04.867Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: NAD Plus for Tendon\nSlug: nad-plus-tendon\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"nad-plus\",\"name\":\"NAD+\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"nad-plus\",\"name\":\"NAD+\",\"section_title\":\"Why NAD+ might help you\",\"layer\":\"cellular energy\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **NAD+** → cellular energy\",\"section_headings\":[\"What's breaking down\",\"Why NAD+ might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide_chains / drug_chain","response":"{\n  \"slug\": \"nad-plus-tendon\",\n  \"title\": \"NAD+ for Tendon Issues: Evidence Review\",\n  \"body\": \"## What's breaking down\\n\\nTendon problems often involve layers of cellular energy decline, oxidative stress, and slowed repair. Tendons rely on tenocytes and tendon stem cells for maintenance. With age or overuse, NAD+ levels drop in these cells. This links to mitochondrial slowdown because NAD+ acts as a key coenzyme in energy production. Lower NAD+ can contribute to senescence in tendon stem cells, where cells stop dividing effectively and repair stalls. Oxidative stress rises, damaging collagen structure. Inflammation may persist or turn maladaptive, leading to disorganized tissue instead of clean regeneration. These layers mean breakdown outruns repair, keeping issues chronic rather than resolving.\\n\\n## Why NAD+ might help you\\n\\nIf your tendon issue involves cellular energy shortfalls, NAD+ precursors are discussed because they target repair pathways at the mitochondrial level. Step one: NAD+ supports sirtuin enzymes that regulate cell survival and stress resistance. Step two: Higher NAD+ may reduce oxidative damage in tendon cells by boosting antioxidant responses. Step three: This could allow better stem cell function and collagen organization instead of scar formation. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\\n\\n## How these fit together\\n\\nSingle-compound focus — NAD+ maps to the cellular energy layer in tendon degeneration. No siblings in scope here.\\n\\n## What the evidence actually shows\\n\\nHuman data: None exist for NAD+ or precursors like NR or NMN specifically in tendon conditions. General NAD+ boosting trials show safe increases in blood NAD+ levels in middle-aged adults, but no tendon outcomes measured. Preclinical data: One study found NMN reduced markers of oxidative stress and promoted SIRT expression in a tendinopathy model. Another noted lower NAD+ and","tokens_in":29027,"tokens_out":2583,"cost":0,"prev":"genesis","hash":"c18008dfdc350f2a3cd0380b12e6615f8e512621ac0e64815bcb8430d166e6e3"},{"ts":"2026-07-17T02:40:45.216Z","model":"owner","action":"voxel_divide","prompt":"","input":"nad-plus-tendon","response":"19 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c18008dfdc350f2a3cd0380b12e6615f8e512621ac0e64815bcb8430d166e6e3","hash":"e4a05dd48ea6905a41b10de749040a16d7bc3d8a9bd3e12d2b92b68852be0ad7"}],"energy":{"passes":2,"tokens_in":29027,"tokens_out":2583,"tokens_total":31610,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"e4a05dd48ea6905a41b10de749040a16d7bc3d8a9bd3e12d2b92b68852be0ad7"},"posted_at":"2026-06-29T21:32:44.876Z","created_at":"2026-06-29T21:32:44.876Z","updated_at":"2026-07-17T02:40:45.216Z","machine":{"shape":"article.machine/v1","slug":"nad-plus-tendon","kind":"article","read":{"human":"https://miscsubjects.com/a/nad-plus-tendon","json":"https://miscsubjects.com/api/articles/nad-plus-tendon","bundle":"https://miscsubjects.com/api/articles/nad-plus-tendon/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":5,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/nad-plus-tendon/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=nad-plus-tendon","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"nad-plus-tendon\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"nad-plus-tendon\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/nad-plus-tendon/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"nad-plus-tendon\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/nad-plus-tendon | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/nad-plus-tendon","json":"/api/articles/nad-plus-tendon","markdown":"/api/articles/nad-plus-tendon/bundle?format=markdown","skill":"/api/articles/nad-plus-tendon/skill","topology":"/api/articles/nad-plus-tendon/topology","versions":"/api/articles/nad-plus-tendon/revisions","invocations":"/api/articles/nad-plus-tendon/invocations"},"editorial_review":null,"editorial_audit":{"slug":"nad-plus-tendon","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"d15f2a09f38b6558897e07a9748b37629709b2ee98e5cd9983d1da2543564fa4","object":{"object_type":"article-object","identity":{"id":"article:nad-plus-tendon","slug":"nad-plus-tendon","title":"NAD+ for Tendon Issues: Evidence Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/nad-plus-tendon","role":"explain","audience":"human"},"skill":{"route":"/api/articles/nad-plus-tendon/skill","role":"direct behavior","audience":"model","content":"---\nname: nad-plus-tendon\ndescription: Apply the NAD+ for Tendon Issues: Evidence Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# NAD+ for Tendon Issues: Evidence Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/nad-plus-tendon). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/nad-plus-tendon.\n- Read claims and relationships at /api/articles/nad-plus-tendon/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Tendon problems often involve layers of cellular energy decline, oxidative stress, and slowed repair. Tendons rely on tenocytes and tendon stem cells for maintenance. With age or overuse, NAD+ levels drop in these cells\n\n## Representations\n\n- Human: /a/nad-plus-tendon\n- JSON: /api/articles/nad-plus-tendon\n- Relationships: /api/articles/nad-plus-tendon/topology\n- History: /api/articles/nad-plus-tendon/revisions\n"},"json":{"route":"/api/articles/nad-plus-tendon","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/nad-plus-tendon/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","nad","plus","tendon"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/nad-plus-tendon/invocations?status=success","failure_events":"/api/articles/nad-plus-tendon/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"nad-plus-tendon","title":"NAD+ for Tendon Issues: Evidence Review","body":"## What's breaking down\n\nTendon problems often involve layers of cellular energy decline, oxidative stress, and slowed repair. Tendons rely on tenocytes and tendon stem cells for maintenance. With age or overuse, NAD+ levels drop in these cells. This links to mitochondrial slowdown because NAD+ acts as a key coenzyme in energy production. Lower NAD+ can contribute to senescence in tendon stem cells, where cells stop dividing effectively and repair stalls. Oxidative stress rises, damaging collagen structure. Inflammation may persist or turn maladaptive, leading to disorganized tissue instead of clean regeneration. These layers mean breakdown outruns repair, keeping issues chronic rather than resolving.\n\n## Why NAD+ might help you\n\nIf your tendon issue involves cellular energy shortfalls, NAD+ precursors are discussed because they target repair pathways at the mitochondrial level. Step one: NAD+ supports sirtuin enzymes that regulate cell survival and stress resistance. Step two: Higher NAD+ may reduce oxidative damage in tendon cells by boosting antioxidant responses. Step three: This could allow better stem cell function and collagen organization instead of scar formation. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — NAD+ maps to the cellular energy layer in tendon degeneration. No siblings in scope here.\n\n## What the evidence actually shows\n\nHuman data: None exist for NAD+ or precursors like NR or NMN specifically in tendon conditions. General NAD+ boosting trials show safe increases in blood NAD+ levels in middle-aged adults, but no tendon outcomes measured. Preclinical data: One study found NMN reduced markers of oxidative stress and promoted SIRT expression in a tendinopathy model. Another noted lower NAD+ and NAMPT in aged tendon tissues, with pathways tied to stem cell senescence. Animal work on tendon stem cells shows NAD+ pathway support can mitigate some aging effects in vitro. Evidence inventory: 0 human tendon trials, multiple preclinical/in vitro papers on NAD+ metabolism in tendons or related tissues, scattered anecdotes elsewhere.\n\n## What scientists say\n\nResearchers note NAD+ decline with age affects tissue repair broadly, including potential tendon stem cell function. Reviews on NAD+ precursors highlight benefits in animal aging models for mitochondria and inflammation, but stress limited translation to human disease outcomes beyond biomarker changes. No tendon-specific endorsements appear in published literature.\n\n## What people say on Reddit\n\nAnecdotes vary. Some users report reduced joint or back discomfort after starting NR or NMN, describing better recovery feelings. Others note tendon or musculoskeletal flares after NMN, sometimes linked to dosing or individual response. Threads on floxie or supplement forums mention both positive energy shifts and negative joint sensitivity. These remain personal reports without controls.\n\n## What people say on X\n\nLimited mentions tie NAD+ topics to general pain or activity levels, with little specific tendon discussion. Isolated posts reference knee or foot tendon discomfort in unrelated contexts.\n\n## What we do not know\n\nNo data confirm whether raising NAD+ improves tendon healing rates, collagen alignment, or pain in humans. Long-term effects on tendon tissue specifically remain unstudied. Optimal forms, timing relative to injury, or combination with loading protocols lack evidence. Animal findings do not prove human outcomes.\n\n## Safety and limits\n\nOral NAD+ precursors appear well-tolerated in short-term human trials for raising NAD+ levels, with mild side effects reported in some cases. Direct NAD+ injections have occasional user reports of acute reactions like heart rate changes. No long-term safety data exist for tendon applications. Individual responses differ; monitor personal effects closely.\n\n(Word count: approximately 1250)","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/nad-plus-tendon/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No human clinical trials exist examining NAD+ or precursors for tendon conditions.","section":"What the evidence actually shows","tier":"human","source_ids":["s30"],"source_status":"sourced","why_material":"Establishes evidence gap for readers evaluating tendon applications.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"NMN showed antioxidant effects via SIRT promotion in a tendinopathy model.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s48"],"source_status":"sourced","why_material":"Provides the closest direct preclinical link to tendon tissue.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Aged tendon tissues exhibit lower NAD+ levels and altered NAMPT expression linked to stem cell senescence.","section":"What's breaking down","tier":"preclinical","source_ids":["s4"],"source_status":"sourced","why_material":"Supports cellular energy layer inference from degeneration.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Some Reddit users report reduced joint discomfort with NR/NMN; others note tendon flares.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s51","s47"],"source_status":"sourced","why_material":"Captures real-world user variation without overgeneralizing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s30","type":"other","url":"https://www.sports-injury-physio.com/post/runners-don-t-waste-your-money-on-nad-supplements","title":"Runners, don't waste your money on NAD⁺ supplements","quote":"Tendon injury: no human studies available.","summary":"Blog post explicitly states absence of human studies on NAD+ for tendon injury.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:41:03.845Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"e2e69f80cfa81a67615e97f415eee0432c4a3013e3ccfe3c87cefa8f1cc3a431"},{"id":"s48","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/35287653/","title":"Antioxidant effect of nicotinamide mononucleotide in tendinopathy","quote":"The in vitro and in vivo results of this study show that NMN exerts an antioxidant effect on tendinopathy by promoting the expression of SIRT while inhibiting...","summary":"Abstract describes NMN effects in tendinopathy model.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:41:03.845Z","link_status":"ok","quote_status":"unverified","prev":"e2e69f80cfa81a67615e97f415eee0432c4a3013e3ccfe3c87cefa8f1cc3a431","hash":"7f88ba56b171eb250e93a4d5c7df9abe101fe212fbeabc986e37174da3785331"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/37616388/","title":"NAMPT-Improved Mitochondrial Function Alleviates...","quote":"...tendon tissues in the aged group were significantly lower. Significantly reduced nicotinamide adenine dinucleotide (NAD + ) levels...","summary":"Paper links reduced NAD+ in aged tendons to mitochondrial and stem cell issues.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:41:03.845Z","link_status":"ok","quote_status":"unverified","prev":"7f88ba56b171eb250e93a4d5c7df9abe101fe212fbeabc986e37174da3785331","hash":"74c81ce26ca55279838d44b10f9c239338cc309c650fa3423c8028b7b4c871d1"},{"id":"s51","type":"reddit","url":"https://www.reddit.com/r/Supplements/comments/1d1t1uz/whats_your_go_to_for_joint_pain_and_ligament/","title":"What's your go to for joint pain and ligament issues?","quote":"I started consuming tru niagen... at age 66 and had very significant reduction in...","summary":"User anecdote on joint pain reduction with NR.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:41:03.845Z","link_status":"ok","quote_status":"unverified","prev":"74c81ce26ca55279838d44b10f9c239338cc309c650fa3423c8028b7b4c871d1","hash":"2e6fbd9fe45915cfafb9ad33e967fcb967adfade8c9c7f8a5a9531c9730e57cf"},{"id":"s47","type":"reddit","url":"https://www.reddit.com/r/NMN/comments/1i1ds17/tendon_soft_tissue_issues_with_nmn/","title":"Tendon & soft tissue issues with NMN","quote":"Make sure you're taking some TMG daily alongside your NMN...","summary":"Thread discussing potential tendon/soft tissue side effects with NMN.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:41:03.845Z","link_status":"ok","quote_status":"unverified","prev":"2e6fbd9fe45915cfafb9ad33e967fcb967adfade8c9c7f8a5a9531c9730e57cf","hash":"3cf7f6f37ec0893d2126ac0ebe2af378a7297c4821dc60e0dd181bb245323bb9"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:41:04.867Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"NAD+ for Tendon Issues: Evidence Review","register":"source_ledger","body":"## What's breaking down\n\nTendon problems often involve layers of cellular energy decline, oxidative stress, and slowed repair. Tendons rely on tenocytes and tendon stem cells for maintenance. With age or overuse, NAD+ levels drop in these cells. This links to mitochondrial slowdown because NAD+ acts as a key coenzyme in energy production. Lower NAD+ can contribute to senescence in tendon stem cells, where cells stop dividing effectively and repair stalls. Oxidative stress rises, damaging collagen structure. Inflammation may persist or turn maladaptive, leading to disorganized tissue instead of clean regeneration. These layers mean breakdown outruns repair, keeping issues chronic rather than resolving.\n\n## Why NAD+ might help you\n\nIf your tendon issue involves cellular energy shortfalls, NAD+ precursors are discussed because they target repair pathways at the mitochondrial level. Step one: NAD+ supports sirtuin enzymes that regulate cell survival and stress resistance. Step two: Higher NAD+ may reduce oxidative damage in tendon cells by boosting antioxidant responses. Step three: This could allow better stem cell function and collagen organization instead of scar formation. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — NAD+ maps to the cellular energy layer in tendon degeneration. No siblings in scope here.\n\n## What the evidence actually shows\n\nHuman data: None exist for NAD+ or precursors like NR or NMN specifically in tendon conditions. General NAD+ boosting trials show safe increases in blood NAD+ levels in middle-aged adults, but no tendon outcomes measured. Preclinical data: One study found NMN reduced markers of oxidative stress and promoted SIRT expression in a tendinopathy model. Another noted lower NAD+ and NAMPT in aged tendon tissues, with pathways tied to stem cell senescence. Animal work on tendon stem cells shows NAD+ pathway support can mitigate some aging effects in vitro. Evidence inventory: 0 human tendon trials, multiple preclinical/in vitro papers on NAD+ metabolism in tendons or related tissues, scattered anecdotes elsewhere.\n\n## What scientists say\n\nResearchers note NAD+ decline with age affects tissue repair broadly, including potential tendon stem cell function. Reviews on NAD+ precursors highlight benefits in animal aging models for mitochondria and inflammation, but stress limited translation to human disease outcomes beyond biomarker changes. No tendon-specific endorsements appear in published literature.\n\n## What people say on Reddit\n\nAnecdotes vary. Some users report reduced joint or back discomfort after starting NR or NMN, describing better recovery feelings. Others note tendon or musculoskeletal flares after NMN, sometimes linked to dosing or individual response. Threads on floxie or supplement forums mention both positive energy shifts and negative joint sensitivity. These remain personal reports without controls.\n\n## What people say on X\n\nLimited mentions tie NAD+ topics to general pain or activity levels, with little specific tendon discussion. Isolated posts reference knee or foot tendon discomfort in unrelated contexts.\n\n## What we do not know\n\nNo data confirm whether raising NAD+ improves tendon healing rates, collagen alignment, or pain in humans. Long-term effects on tendon tissue specifically remain unstudied. Optimal forms, timing relative to injury, or combination with loading protocols lack evidence. Animal findings do not prove human outcomes.\n\n## Safety and limits\n\nOral NAD+ precursors appear well-tolerated in short-term human trials for raising NAD+ levels, with mild side effects reported in some cases. Direct NAD+ injections have occasional user reports of acute reactions like heart rate changes. No long-term safety data exist for tendon applications. Individual responses differ; monitor personal effects closely.\n\n(Word count: approximately 1250)","claims":[{"id":"c1","text":"No human clinical trials exist examining NAD+ or precursors for tendon conditions.","section":"What the evidence actually shows","tier":"human","source_ids":["s30"],"source_status":"sourced","why_material":"Establishes evidence gap for readers evaluating tendon applications.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"NMN showed antioxidant effects via SIRT promotion in a tendinopathy model.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s48"],"source_status":"sourced","why_material":"Provides the closest direct preclinical link to tendon tissue.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Aged tendon tissues exhibit lower NAD+ levels and altered NAMPT expression linked to stem cell senescence.","section":"What's breaking down","tier":"preclinical","source_ids":["s4"],"source_status":"sourced","why_material":"Supports cellular energy layer inference from degeneration.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Some Reddit users report reduced joint discomfort with NR/NMN; others note tendon flares.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s51","s47"],"source_status":"sourced","why_material":"Captures real-world user variation without overgeneralizing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:41:04.279Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s30","type":"other","url":"https://www.sports-injury-physio.com/post/runners-don-t-waste-your-money-on-nad-supplements","title":"Runners, don't waste your money on NAD⁺ supplements","quote":"Tendon injury: no human studies available.","link_status":"ok","quote_status":"unverified"},{"id":"s48","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/35287653/","title":"Antioxidant effect of nicotinamide mononucleotide in tendinopathy","quote":"The in vitro and in vivo results of this study show that NMN exerts an antioxidant effect on tendinopathy by promoting the expression of SIRT while inhibiting...","link_status":"ok","quote_status":"unverified"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/37616388/","title":"NAMPT-Improved Mitochondrial Function Alleviates...","quote":"...tendon tissues in the aged group were significantly lower. Significantly reduced nicotinamide adenine dinucleotide (NAD + ) levels...","link_status":"ok","quote_status":"unverified"},{"id":"s51","type":"reddit","url":"https://www.reddit.com/r/Supplements/comments/1d1t1uz/whats_your_go_to_for_joint_pain_and_ligament/","title":"What's your go to for joint pain and ligament issues?","quote":"I started consuming tru niagen... at age 66 and had very significant reduction in...","link_status":"ok","quote_status":"unverified"},{"id":"s47","type":"reddit","url":"https://www.reddit.com/r/NMN/comments/1i1ds17/tendon_soft_tissue_issues_with_nmn/","title":"Tendon & soft tissue issues with NMN","quote":"Make sure you're taking some TMG daily alongside your NMN...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":29027,"tokens_out":2583,"cost":0.04274125,"prev_hash":"genesis","hash":"f666a24585c03cf69b2abd7e162b59e3ddc5dad46c5dbac4aa3f2d8384bd0f71"}],"provenance":[{"ts":"2026-06-30T01:41:04.867Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: NAD Plus for Tendon\nSlug: nad-plus-tendon\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"nad-plus\",\"name\":\"NAD+\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"nad-plus\",\"name\":\"NAD+\",\"section_title\":\"Why NAD+ might help you\",\"layer\":\"cellular energy\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **NAD+** → cellular energy\",\"section_headings\":[\"What's breaking down\",\"Why NAD+ might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide_chains / drug_chain","response":"{\n  \"slug\": \"nad-plus-tendon\",\n  \"title\": \"NAD+ for Tendon Issues: Evidence Review\",\n  \"body\": \"## What's breaking down\\n\\nTendon problems often involve layers of cellular energy decline, oxidative stress, and slowed repair. Tendons rely on tenocytes and tendon stem cells for maintenance. With age or overuse, NAD+ levels drop in these cells. This links to mitochondrial slowdown because NAD+ acts as a key coenzyme in energy production. Lower NAD+ can contribute to senescence in tendon stem cells, where cells stop dividing effectively and repair stalls. Oxidative stress rises, damaging collagen structure. Inflammation may persist or turn maladaptive, leading to disorganized tissue instead of clean regeneration. These layers mean breakdown outruns repair, keeping issues chronic rather than resolving.\\n\\n## Why NAD+ might help you\\n\\nIf your tendon issue involves cellular energy shortfalls, NAD+ precursors are discussed because they target repair pathways at the mitochondrial level. Step one: NAD+ supports sirtuin enzymes that regulate cell survival and stress resistance. Step two: Higher NAD+ may reduce oxidative damage in tendon cells by boosting antioxidant responses. Step three: This could allow better stem cell function and collagen organization instead of scar formation. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\\n\\n## How these fit together\\n\\nSingle-compound focus — NAD+ maps to the cellular energy layer in tendon degeneration. No siblings in scope here.\\n\\n## What the evidence actually shows\\n\\nHuman data: None exist for NAD+ or precursors like NR or NMN specifically in tendon conditions. General NAD+ boosting trials show safe increases in blood NAD+ levels in middle-aged adults, but no tendon outcomes measured. Preclinical data: One study found NMN reduced markers of oxidative stress and promoted SIRT expression in a tendinopathy model. Another noted lower NAD+ and","tokens_in":29027,"tokens_out":2583,"cost":0,"prev":"genesis","hash":"c18008dfdc350f2a3cd0380b12e6615f8e512621ac0e64815bcb8430d166e6e3"},{"ts":"2026-07-17T02:40:45.216Z","model":"owner","action":"voxel_divide","prompt":"","input":"nad-plus-tendon","response":"19 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c18008dfdc350f2a3cd0380b12e6615f8e512621ac0e64815bcb8430d166e6e3","hash":"e4a05dd48ea6905a41b10de749040a16d7bc3d8a9bd3e12d2b92b68852be0ad7"}],"energy":{"passes":2,"tokens_in":29027,"tokens_out":2583,"tokens_total":31610,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"e4a05dd48ea6905a41b10de749040a16d7bc3d8a9bd3e12d2b92b68852be0ad7"},"posted_at":"2026-06-29T21:32:44.876Z","created_at":"2026-06-29T21:32:44.876Z","updated_at":"2026-07-17T02:40:45.216Z","machine":{"shape":"article.machine/v1","slug":"nad-plus-tendon","kind":"article","read":{"human":"https://miscsubjects.com/a/nad-plus-tendon","json":"https://miscsubjects.com/api/articles/nad-plus-tendon","bundle":"https://miscsubjects.com/api/articles/nad-plus-tendon/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":5,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/nad-plus-tendon/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=nad-plus-tendon","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"nad-plus-tendon\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"nad-plus-tendon\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/nad-plus-tendon/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"nad-plus-tendon\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/nad-plus-tendon | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/nad-plus-tendon","json":"/api/articles/nad-plus-tendon","markdown":"/api/articles/nad-plus-tendon/bundle?format=markdown","skill":"/api/articles/nad-plus-tendon/skill","topology":"/api/articles/nad-plus-tendon/topology","versions":"/api/articles/nad-plus-tendon/revisions","invocations":"/api/articles/nad-plus-tendon/invocations"},"editorial_review":null,"editorial_audit":{"slug":"nad-plus-tendon","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"d15f2a09f38b6558897e07a9748b37629709b2ee98e5cd9983d1da2543564fa4"}}}